FDA Approves Alembic’s Generic Acitretin Capsules USP, 10mg, 17.5mg, and 25mg

August 7, 2024

Get Involved: NPF Launches Annual Take ACTION Campaign for Psoriasis Action Month

August 1, 2024

Putting Patients First: Pearls on Improving Access to PsO Medications

July 30, 2024

News Your Patients Can Use: Walmart Expands Autoimmune-Focused Care to 25 More Pharmacies Across Five States

July 25, 2024

New International Consensus Statement Defines GPP, Updates Diagnostic Criteria

June 7, 2024

Sotyktu Demonstrates Durable Response Rates, Consistent Safety in Moderate-to-Severe Plaque PsO

May 17, 2024

FDA Green Lights New Stelara Biosimilar

April 16, 2024

Paragon Therapeutics’ Oruka Merges With ARCA to Advance Novel Treatments for PsO, PsA

April 3, 2024

Rodney Cotton Joins Castle Biosciences’ Board of Directors

March 28, 2024

IKBKB Genetic Mutation Implicated in PsO, PsA

March 25, 2024

GPP Vs. AGEP: Newly Developed Scoring System Helps Dermatologists Make the Differential Dx

March 21, 2024

FDA Expands Spevigo Approval to Include Teens With GPP

March 19, 2024